| ARP | absolute refractory period; American Registry of Pathologists; anticipated recovery path; apolipopro... |
|---|---|
| BP | Bachelor of Pharmacy; back pressure; barometric pressure; basic protein; bathroom privileges; bed pa... |
| CAP | camptodactyly-arthropathy-pericarditis [syndrome]; Canada Assistance Plan; capsule; captopril; catab... |
| CMP | cardiomyopathy; cartilage matrix protein; chondromalacia patellae; collagen binding protein; competi... |
| DP | data processing; deep pulse; definitive procedure; degradation product; degree of polymerization; de... |
| congenital protein C or s deficiency | This inherited disorder of blood coagulation is characterised by a deficiency of vitamin K dependent plasma proteins (C and s) that are naturally occurring anticoagulants. This disorder results in an increased risk of blood clot formation within the circulatory system. (27 Sep 1997) |
|---|---|
| conjugated protein | A protein that contains atleast one prosthetic group. (09 Oct 1997) |
| copper protein | A protein containing one or more copper ions; e.g., cytochrome c oxidase, phenol oxidase. (05 Mar 2000) |
| core II protein, ubiquinol-cytochrome c reductase | <chemical> Member of the mitochondrial-protein-processing family; protein found in subunits of ubiquinol-cytochrome c reductase; amino acid sequence given in first source Synonym: core II protein, uccreductase (26 Jun 1999) |
| core I protein, ubiquinol-cytochrome c reductase | <chemical> Member of the mitochondrial-protein-processing family; protein found in subunits of ubiquinol-cytochrome c reductase; amino acid sequence given in first source Synonym: core I protein, uccreductase (26 Jun 1999) |
| myelin basic protein | <protein> Major component of the myelin sheath in mammalian CNS. Used as an antigen will induce a allergic encephalitis, possibly a model for some neurodegenerative disorders. (18 Nov 1997) |
| myelin basic protein kinase | <enzyme> Protein from pig brain activates ATP-mg-dependent protein phosphatase; a protein tau kinase; a multisubstrate kinase; in texts written as f subscript a Registry number: EC 2.7.1.- Synonym: protein phosphatase activator fa, glycogen synthase kinase 3, protein kinase f(a), gsk-3, gsk-3alpha, kinase f(a), gsk-3beta, mds1 gene product, p63(samk), src-activated mbp kinase, p63(mapk) (26 Jun 1999) |
| corticosteroid-binding protein | <chemical> Chemical name: Transcortins (12 Dec 1998) |
| myelin p0 protein | A protein that accounts for more than half of the peripheral nervous system myelin protein. The extracellular domain of this protein is believed to engage in adhesive interactions and thus hold the myelin membrane compact. It can behave as a homophilic adhesion molecule through interactions with its extracellular domains. (12 Dec 1998) |
| myelin p2 protein | A positively charged protein found in peripheral nervous system myelin. Sensitive immunological techniques have demonstrated that p2 is expressed in small amounts of central nervous system myelin sheaths of some species. It is an antigen for experimental allergic neuritis (neuritis, experimental allergic), the peripheral nervous system counterpart of experimental allergic encephalomyelitis. (12 Dec 1998) |
| myelin protein A1 | An important protein in the central nervous system. Synonym: myelin protein A1. (05 Mar 2000) |
| myelin proteolipid protein | A myelin protein that is the major component of the organic solvent extractable lipoprotein complexes of whole brain. It has been the subject of much study because of its unusual physical properties. It remains soluble in chloroform even after essentially all of its bound lipids have been removed. (12 Dec 1998) |
| myeloblastic protein | See: human leukaemia-associated antigens. (05 Mar 2000) |
| myeloma protein | <haematology, oncology> The immunoglobulins and Bence Jones proteins secreted by myeloma cells. (18 Nov 1997) |
| myod protein | A myogenic regulatory factor that controls myogenesis. Though it is not clear how its function differs from the other myogenic regulatory factors, myod appears to be related to fusion and terminal differentiation of the muscle cell. (12 Dec 1998) |